local_hospital

SGS proderm GmbH

Address
lock Available on a paid plan

Skin and Connective Tissue Diseases

At SGS proderm GmbH in Schenefeld, clinical research in skin and connective tissue diseases focuses on common conditions such as atopic dermatitis and related eczema. The studies are designed to evaluate new moisturisers and skin-care approaches that may help improve the skin barrier, reduce irritation, and prevent symptom relapse.

  • Testing whether new moisturisers can help prevent eczema flare-ups in children with atopic dermatitis
  • Assessing skin-barrier strengthening in adults with a history of atopic dermatitis
  • Studying irritation and comfort outcomes for products intended for sensitive skin

This area combines practical dermatology research with a strong focus on everyday skin health and better supportive care.

Hormonal Diseases

Research in hormonal diseases includes studies on female androgenetic alopecia, a form of hair loss linked to hormonal influences. The trials are aimed at evaluating treatment effectiveness and comparing options that may improve hair growth and hair density in women.

  • Evaluating oral and topical treatments for female androgenetic alopecia
  • Measuring changes in hair counts to understand treatment benefit over time
  • Comparing active therapy with control approaches to assess effectiveness

The work reflects a broader interest in visible, quality-of-life-impacting conditions where treatment response matters to patients.

Respiratory Tract Diseases and Virus Diseases

The site also supports studies in respiratory tract diseases and virus diseases, with a focus on Respiratory Syncytial Virus infections. These trials are centered on vaccine research, especially understanding immune response and safety in older adults.

  • Evaluating the immune response after revaccination against Respiratory Syncytial Virus
  • Monitoring safety and tolerability in adults aged 60 years and above
  • Supporting vaccine research aimed at better protection from viral respiratory illness

This therapeutic area highlights preventive medicine and the development of stronger defenses against seasonal respiratory infections.

Analytical, Diagnostic and Therapeutic Techniques and Equipment

Another part of the research portfolio involves analytical, diagnostic and therapeutic techniques and equipment, with studies in healthy volunteers and product-use settings. These trials help assess how topical treatments behave on the skin and whether they are suitable for everyday use.

  • Investigating how topical pain-relief products interact with the skin
  • Studying irritation potential and product tolerability in healthy participants
  • Supporting the development and evaluation of skin-applied therapeutic products

This work provides useful evidence for improving product performance, safety, and practical use in routine care.

Not possible to specify

Some trials at the Clinical Research Unit cover broader or mixed research questions that do not fit neatly into a single disease category. These include studies in healthy volunteers and investigations of cosmetic or dermatologic products such as treatments for glabellar lines.

  • Assessing safety and tolerability in aesthetic and dermatologic research
  • Including healthy participants in studies of skin-related products
  • Exploring practical use and user experience across different product types

This range shows a flexible research program that spans both medical and appearance-related applications.

Site Overview

assignment
7
connected trials
corporate_fare
6
sponsors
science
15
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
7
Total trials linked
Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
6
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
7
Outperforms 78% of sites
public
Therapeutic diversity
6areas
Outperforms 92% of sites
groups
Sponsor diversity
6sponsors
Outperforms 78% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in SGS proderm GmbH

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A phase IV randomised, double-blind, parallel-design, controlled multi-center trial of a NOVel moisturiser for Atopic dermatitis: effect on relapse prevention in children, NOVA IIACO Hud Nordic ABPhase IIINot RecruitingFeb 2023May 2024

IMP list

lock Showing 1 of 15 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Glycerol2Unknown2023-02-132023-12-07

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.